Skip to main content

4583 · Chiome Bioscience Inc. · Financials

76 JPY -1 (-1.30%) At close · Nov 12
Market Cap
6.17B JPY
Shares
81.13M
Volume · Nov 12 957K Avg daily vol (3M) 1.6M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
593.29M -24%
FY2025 Revenue FY2021–FY2025
Net Income
-982.78M +3.7%
FY2025 Net Income FY2021–FY2025
Gross Margin
59.93% +4.5pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
-165.14% -33.1pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
-935.99M +6.5%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
JPY 593.29M 780.81M 682.46M 630.82M 712.93M
JPY 237.71M 347.96M 283.87M 281.96M 290.47M
JPY 355.58M 432.85M 398.6M 348.86M 422.46M
JPY -979.77M -1.03B -1.21B -1.26B -1.33B
JPY -979.54M -1.02B -1.22B -1.24B -1.47B
JPY 3.24M 3.24M 5.01M 5.01M 13.49M
JPY -982.78M -1.02B -1.22B -1.24B -1.48B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.